Haffkine Bio-Pharmaceutical Corporation Limited, a active private limited state government company, was established on 28 March 1974 in Mumbai, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24239MH1974SGC017341. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.71 Cr.
It upholds a compliant status. Employing 273 professional, Its leadership includes Ashok Nagurao Karanjkar (Director), Deepak Ramdas Pednekar (Director), Deelip Govindrao Mhaisekar (Director). Past directors included Abhay Sadashiv Chowdhary, Jayesh Ramesh Bellare, Prakash Ranganath Sabade. It holds ₹47.95 Cr open charges and ₹129.19 Cr settled loans. Its latest AGM occurred on 30 December 2022, with the balance sheet filed on 31 March 2022. It is based at Acharya Donde Marg, Parel,, Mumbai, Maharashtra, 400012.
U24239MH1974SGC017341
017341
28 March 1974
₹10.00 Cr
₹8.71 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Haffkine Bio-Pharmaceutical Corporation Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashok Nagurao Karanjkar | Director | 10 Aug 2022 | Current |
| Deepak Ramdas Pednekar | Director | 28 Jan 2021 | Current |
| Deelip Govindrao Mhaisekar | Director | 05 Jul 2021 | Current |
| Saurabh Vijay | Director | 27 Jul 2020 | Current |
| Dimple Kasana | Director | 17 Oct 2021 | Current |
| Mary Neelima Kerketta | Director | 01 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 May 2015 | Past |
| Pramod Abcsdd | Director | 07 Jun 2014 | Past |
| Pramod Abcsdd | Managing Director | 29 Jan 2013 | Past |
| Pramod Abcsdd | Managing Director | 17 Jun 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Managing Director | 20 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Haffkine Bio-Pharmaceutical Corporation Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.97% increase. The company also saw a substantial improvement in profitability, with a 31.48% increase in profit. The company's net worth dipped by a decrease of 9.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Haffkine Bio-Pharmaceutical Corporation had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹479,500,000.00
₹1,291,932,300.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 1997 | Canara Bank | ₹47.95 Cr | Open |
| 03 Oct 2007 | Canara Bank | ₹20.00 Cr | Satisfied |
| 31 Oct 2002 | Canara Bank | ₹14.25 Cr | Satisfied |
| 21 Oct 2002 | Canara Bank | ₹2.73 Cr | Satisfied |
| 24 Apr 2002 | Canara Bank | ₹7.27 M | Satisfied |
Explore comprehensive loan charge details -
Haffkine Bio-Pharmaceutical Corporation has a workforce of 273 employees as of Oct 17, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Haffkine Bio-Pharmaceutical Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haffkine Bio-Pharmaceutical Corporation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sunil Balajirao Mahindrakar was appointed as a Managing Director was appointed as a Managing Director on 18 Jul 2025 & has been associated with this company since 4 months 14 days . was recorded as a recent event.
The activity Haffkine Bio-Pharmaceutical Corporation Limited last Annual general meeting of members was held on 30 Dec 2022 as per latest MCA records. was completed.
Ashok Nagurao Karanjkar was appointed as a Director was appointed as a Director on 10 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The activity A charge registered on 01 Feb 1994 via Charge ID 90217757 with Industrail Development Bank Of India was fully satisfied on 21 Jun 2022. was completed.
A charge registered on 30 Aug 1990 via Charge ID 90217431 with Bank Of India was fully satisfied on 23 May 2022. was recorded as a recent event.
The activity A charge with Canara Bank of Rs. 47.95 Cr registered on 05 Jun 1997 with Charge ID 90218093 was modified on 20 May 2022. was completed.
In addition, the hospital is asking patients to purchase medicines from private pharmaceuticals as a result of which it is the patients who are shelling out more for paracetamol, antibiotics and other drugs. .
High-level meeting determines that Haffkine was not updated with list of types and quantities of meds it had to supply; now, demands made during tendering to be considered final, adjustments done internally.
Mumbai: The Maharashtra government today made it mandatory for all its departments that provide medical services to purchase medicines, allied materials, and equipment only from Haffkine... .
The CIN of Haffkine Bio-Pharmaceutical Corporation Limited is U24239MH1974SGC017341.
Haffkine Bio-Pharmaceutical Corporation Limited is headquartered at Acharya Donde Marg, Parel,, Mumbai, Maharashtra, 400012.
Haffkine Bio-Pharmaceutical Corporation Limited was incorporated on 28 March 1974.
The current directors of Haffkine Bio-Pharmaceutical Corporation Limited are
The primary industry of Haffkine Bio-Pharmaceutical Corporation Limited is Manufacturing.
Haffkine Bio-Pharmaceutical Corporation Limited is unlisted.
The authorized capital of Haffkine Bio-Pharmaceutical Corporation Limited is ₹10.00 Cr, and the paid-up capital is ₹8.71 Cr.
The compliance status of Haffkine Bio-Pharmaceutical Corporation Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX